Skip to main content
TipRanks
Go Ultimate75% OFF

Open Orphan Plc (HVO) Share Price & Analysis

37 Followers

HVO Stock Chart & Stats

GBX 5.05-GBX 0.15(-2.88%)
At close: 4:30 PM GMT
5 p6 p7 pAug 17Sep 1Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
GBX 4.93 - GBX 5.30
52-Week Range
GBX 4.31 - GBX 11.00
Previous Close
GBX 5.20
Volume
N/A
Average Volume (3M)
1.24M
Market Cap
GBP 34.76M
Enterprise Value
GBP 47.72M
Total Cash (Recent Filing)
GBP 12.98M
Total Debt (Recent Filing)
GBP 13.92M
Price to Earnings (P/E)
―
Beta
1.03
Next Earnings
Apr 14, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
3.96%

Bulls Say, Bears Say

Bulls Say

Record Order Book

The record order book provides revenue visibility beyond the immediate reporting period and into 2027 and 2028. Combined with a 45% increase in proposals and 26% growth in proposal value, it supports the prospect of renewed demand and a stronger medium-term workload.

Differentiated Clinical Platform

Rapid study execution, dedicated recruitment infrastructure and infectious-disease expertise can differentiate hVIVO from conventional research approaches. These capabilities may support customer retention, defend its specialist market position and help convert growing demand for challenge studies into repeat business.

Broader Service Offering

A broader end-to-end offering increases the addressable customer base and creates more opportunities to capture revenue across a drug program. Supporting clients at multiple development stages can deepen relationships, improve cross-selling and reduce reliance on any single service line.

Bears Say

Sharp Profitability Deterioration

The latest annual results show that the earnings profile has become materially weaker and more volatile. Negative gross profit and a sizable net loss reduce internal funding capacity, make recovery dependent on execution, and weaken the financial cushion available for continued investment.

Significant Cash Burn

A reversal from positive cash generation to deep cash outflow increases reliance on existing liquidity or external funding if trading remains weak. Sustained cash burn could constrain investment, reduce strategic flexibility and make the company more exposed to further delays in customer project delivery.

Contract Delays And Margin Pressure

Deferred projects weaken near-term revenue conversion even though management describes them as delayed rather than canceled. The lower-margin second-half mix further limits earnings recovery, while uncertainty over timing and service mix makes sustained profitability harder to forecast.

Open Orphan Plc News

HVO FAQ

What was Open Orphan Plc’s price range in the past 12 months?
Open Orphan Plc lowest share price was 4.31 p and its highest was 11.00 p in the past 12 months.
What is Open Orphan Plc’s market cap?
Open Orphan Plc’s market cap is £34.76M.
When is Open Orphan Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Open Orphan Plc’s earnings last quarter?
Open Orphan Plc released its earnings results on Sep 15, 2026. The company reported -0.008 p earnings per share for the quarter.
Is Open Orphan Plc overvalued?
According to Wall Street analysts Open Orphan Plc’s price is currently Undervalued.
Does Open Orphan Plc pay dividends?
Open Orphan Plc pays an annual dividend of 0.2 p which represents an annual dividend yield of 3.96%. See more information on Open Orphan Plc dividends here
What is Open Orphan Plc’s EPS estimate?
Open Orphan Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Open Orphan Plc have?
Open Orphan Plc has 688,401,060 shares outstanding.
What happened to Open Orphan Plc’s price movement after its last earnings report?
Open Orphan Plc reported an EPS of -0.008 p in its last earnings report. Following the earnings report the stock price went down -4.688%.
Which hedge fund is a major shareholder of Open Orphan Plc?
Currently, no hedge funds are holding shares in GB:HVO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology